## Abstract In this study, the longβterm (>3 years) efficacy of combination therapy for hepatitis B virus (HBV) recurrence and the associated factors were investigated. One hundred and sixtyβfive consecutive HBsAgβpositive patients (92 with liver cirrhosis, 73 with hepatocellular carcinoma; HCC) wh
Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation
β Scribed by Ziv Ben-Ari; Eytan Mor; Zaki Shapira; Ran Tur-Kaspa
- Book ID
- 111722973
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 138 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1527-6465
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Carrier states without significant laboratory abnormali-We analyzed the long-term clinical course of 71 paties are observed in approximately 16%, biochemical abtients with RNA-positive hepatitis C virus (HCV) infecnormalities without symptoms are seen in 60%, and tion after liver transplantation. Pa
Hepatitis B after liver transplantation is often fatal, and no proven medical therapy exists for this condition. We chose to study the potential efficacy of lamivudine therapy for patients with chronic hepatitis B after liver transplantation. Fifty-two patients with chronic hepatitis B after liver t